JWH-250

JWH-250 is a synthetic cannabinoid belonging to the phenylacetylindole class. It was developed as part of scientific research into the endocannabinoid system and the interaction of synthetic compounds with cannabinoid receptors.

The compound is commonly identified as 2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one. It is structurally different from naturally occurring cannabinoids such as THC, although laboratory studies indicate that it can activate the same cannabinoid receptor system.

Chemical information on JWH-250

• Common name: JWH-250
• Chemical class: Phenylacetylindole synthetic cannabinoid
• Molecular formula: C₂₄H₂₅NO₂
• Molecular weight: Approximately 359.46 g/mol
• CAS number: 864445-43-2
• Alternative name: 1-pentyl-3-(2-methoxyphenylacetyl)indole
• Physical form: Often supplied as a laboratory reference material or solid analytical standard, depending on the supplier

Pharmacological characteristics

JWH-250 acts on the body’s cannabinoid receptors, particularly CB1 and CB2 receptors. CB1 receptors are concentrated mainly in the central nervous system, while CB2 receptors are found primarily in immune and peripheral tissues.

 It is a potent cannabinoid-receptor agonist. Its effects cannot be assumed to match those of cannabis or THC because synthetic cannabinoids may activate receptors differently and can produce stronger or less predictable responses.

Reliable human pharmacokinetic and toxicological data remain limited. There is no established safe dose for human use.

Research applications of JWH-250

In controlled scientific settings, JWH-250 may be studied in areas such as:

• Cannabinoid-receptor binding research
• Endocannabinoid-system studies
• Analytical chemistry
• Forensic toxicology
• Metabolite identification
• Mass-spectrometry method development
• Reference-standard comparison
• Screening of unknown laboratory or forensic samples

Analytical laboratories may use authenticated JWH-250 reference standards to help identify the parent compound or its metabolites in research specimens.

Metabolism and analytical research

Like many synthetic cannabinoids, JWH-250 is believed to undergo extensive metabolism. Research has examined transformations such as hydroxylation, oxidation and modification of its pentyl side chain and aromatic groups.

Because the parent compound may be present only briefly or at low concentrations, forensic and toxicology laboratories may look for metabolites rather than relying exclusively on detection of unchanged JWH-250.

The exact metabolic profile can depend on the analytical method, biological system and study conditions.

Safety and toxicology

JWH-250 has not been approved as a medicine, food ingredient, supplement or consumer product. Its safety profile in humans has not been adequately established.

Synthetic cannabinoids as a broader class have been associated with serious adverse effects, including:

• Rapid heart rate
• Elevated blood pressure
• Agitation and severe anxiety
• Confusion
• Hallucinations or psychotic symptoms
• Vomiting
• Loss of consciousness
• Seizures
• Kidney injury
• Cardiovascular complications

These effects are not necessarily specific to JWH-250, but they demonstrate why unapproved synthetic cannabinoids should not be treated as ordinary cannabis substitutes.

JWH-250 is not intended for human or veterinary consumption, self-experimentation, diagnostic use or therapeutic administration.

Laboratory handling

JWH should be handled only by trained personnel in a properly equipped laboratory.

Appropriate laboratory procedures may include:

• Reviewing the applicable Safety Data Sheet
• Wearing suitable gloves, eye protection and protective clothing
• Avoiding inhalation, ingestion and skin contact
• Using appropriate ventilation
• Preventing cross-contamination
• Keeping containers securely closed and clearly labelled
• Restricting access to authorized personnel
• Recording batch, receipt and usage information

Storage requirements should follow the supplier’s authenticated documentation, Certificate of Analysis and Safety Data Sheet.

Quality documentation

A legitimate analytical reference material should be accompanied by documentation that may include:

• Product identity
• Batch or lot number
• Purity or assay information
• Analytical method
• Chromatographic or spectroscopic data
• Storage recommendations
• Date of analysis
• Certificate of Analysis

The batch number on the supplied container should match the batch number shown on the accompanying certificate.

Legal status

JWH-250 is controlled or restricted in many jurisdictions and may also fall under broad synthetic-cannabinoid, analogue or generic drug-control legislation.

Research-use notice

JWH-250 is intended only for legitimate analytical, forensic and laboratory research conducted by qualified professionals. It is not approved for human or veterinary consumption, medical treatment, diagnostic use or household use.